Reconstitution of Lyophilized Powder in Vial Preparation Prior to Injection Injection Procedure For deltoid administration: For gluteal administration: Disposal Procedure For extended-release injectable suspension: 300 mg and 400 mg of lyophilized powder for reconstitution in: The reconstituted extended-release injectable suspension is a uniform, homogeneous suspension that is opaque and milky-white in color
Your PlexusDx provider can recommend the best delivery method based on your lifestyle and health goals
Supplemental Material Figures S1S5 Tables S1S8 Nonstandard Abbreviations and Acronyms ACE angiotensin-converting enzyme ASCVD atherosclerotic cardiovascular disease CAD coronary artery disease CKD chronic kidney disease CRP C-reactive protein CVOT cardiovascular outcomes trial GLP-1 RA glucagon-like peptide-1 receptor agonist HbA1c glycated hemoglobin HR hazard ratio LDL low-density lipoprotein MACE major adverse cardiovascular event SGLT2i sodium-glucose cotransporter-2 inhibitor SOUL Semaglutide Cardiovascular Outcomes Trial T2D type 2 diabetes This manuscript was sent to Jennifer Green, Guest Editor, for review by expert referees, editorial decision, and final disposition
Precautions Before you start Tirzepatide, inform your healthcare provider if you have a history of pancreatitis, a history of thyroid cancer, kidney disease, liver problems, or gastrointestinal issues
Dexpanthenol (B5) Essential for maintaining healthy skin, hair, eyes, and liver
PT-141 (Bremelanotide) is a melanocortin receptor agonist peptide that works through the central nervous system to support sexual desire and arousal
